DA DAVIDSON RAISED PT ON USANA HEALTH SCIENCES AFTER Q2 EARNINGS REPORT

In a report revealed Wednesday, D.A. Davidson analyst Tim Ramey reiterated a Neutral rating on USANA Health Sciences (NYSE: USNA [FREE Stock Trend Analysis]), and raised the worth target from $80.00 to $92.00.

In the report, D.A. Davidson noted, “Q2 operative EPS of $1.72 was up ~55% from $1.11 last year, olympian our $1.23 estimate and therefore the 5-analyst Street mean of $1.33. Results were driven by sales will increase within the Asia Pacific and North America/Europe segments, moreover as a $1.2 million enjoy favorable exchange rates. The rate of thirty three.4% was 40bp on top of our forecast. income of $189.1 million augmented one7.5% year-over-year. On a phase basis, sales in North America grew vi.9%, SE Asia/Pacific was up nine.3%, China augmented thirty six.3%, and North Asia climbed one.5%. Total Active Associates' growth was eight.1%, crystal rectifier by larger China, that grew eighteen.4%. North Asia was the second quickest growing phase, up 12.5%. Active Associates in SE Asia/Pacific grew three.4%, whereas North America was flat.”

USANA Health Sciences closed on Tues at $80.55.